The Graham Number of Arrowhead Pharmaceuticals, Inc. (ARWR) is
11.49.
Graham Number estimates the fair value of a stock using both earnings and book value per share. It is commonly used by value investors to identify undervalued stocks.
| Date |
Value |
| 2026-09-30 |
11.49
|
| 2025-09-30 |
4.33
|
| Ticker |
Name |
Value |
|
EXEL
|
Exelixis Inc
|
25.28
|
|
MGNX
|
MacroGenics Inc
|
7.52
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
58.23
|
|
XNCR
|
Xencor, Inc.
|
19.45
|
|
ABBV
|
AbbVie Inc.
|
10.12
|
|
AMGN
|
Amgen Inc
|
71.69
|
|
MRNA
|
Moderna, Inc.
|
157.32
|
|
ACAD
|
Acadia Pharmaceuticals Inc.
|
19.07
|
|
GILD
|
Gilead Sciences, Inc.
|
53.16
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
60.40
|
|
AMRN
|
Amarin Corporation PLC
|
0.84
|
|
MORF
|
Morphic Holding Inc
|
22.23
|
|
950200.KQ
|
Psomagen Inc
|
1.40
|
|
VCEL
|
Vericel Corporation
|
7.09
|
|
PGEN
|
Precigen, Inc.
|
1.14
|
|
TVTX
|
Travere Therapeutics, Inc.
|
17.42
|
|
VIR
|
Vir Biotechnology, Inc.
|
36.51
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
82.89
|
|
HRTX
|
Heron Therapeutics Inc
|
6.06
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
160.76
|
|
INSM
|
Insmed Incorporated
|
16.76
|
|
ORGO
|
Organogenesis Holdings Inc.
|
4.67
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
544.10
|